Effect of Tussilago farfara L. Polysaccharides on the Content of Hematopoietic Stem Cells (CD117


Journal

Bulletin of experimental biology and medicine
ISSN: 1573-8221
Titre abrégé: Bull Exp Biol Med
Pays: United States
ID NLM: 0372557

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 03 07 2020
pubmed: 25 11 2020
medline: 5 10 2021
entrez: 24 11 2020
Statut: ppublish

Résumé

Myelotoxicity is a serious side effect of anticancer drugs. The search for drugs that can reduce the hematological complications of chemotherapy through modulation of hematopoietic stem cells is an urgent task of oncopharmacology. In the present study we showed that administration of Tussilago farfara L. polysaccharides to C57BL/6 mice treated with cyclophosphamide can increase the number of hematopoietic stem cells (CD117

Identifiants

pubmed: 33231808
doi: 10.1007/s10517-020-05025-y
pii: 10.1007/s10517-020-05025-y
doi:

Substances chimiques

Antigens, CD34 0
Antineoplastic Agents, Alkylating 0
Biomarkers 0
Plant Extracts 0
Polysaccharides 0
Cyclophosphamide 8N3DW7272P
Proto-Oncogene Proteins c-kit EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-174

Auteurs

E A Safonova (EA)

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. safonova_7@mail.ru.

K A Lopatina (KA)

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

A R Dyagel (AR)

Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.

T G Razina (TG)

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

S G Krylova (SG)

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

A M Gur'ev (AM)

Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.

M V Belousov (MV)

Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.

E P Zueva (EP)

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH